EOLS - Company ID 0001570562
The table below shows Evolus, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $73.14M | $68.97M | $69.39M | $68.52M | $61.09M | $66.91M |
| Cost of revenue | $24.24M | $23.13M | $24.07M | $21.87M | $18.99M | $19.84M |
| Gross profit | $48.90M | $45.84M | $45.32M | $46.66M | $42.10M | $47.07M |
| R&D | - | - | - | - | - | - |
Evolus, Inc. reported annual revenue of $297.18M for fiscal year 2025. That is up 11.6% from $266.27M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $51.98M |
| $52.82M |
| $56.67M |
| $56.64M |
| $52.51M |
| $50.15M |
| Operating income | -$6.85M | -$11.50M | -$10.21M | -$15.17M | -$15.47M | -$7.70M |
| Income tax | $256.00K | $167.00K | $53.00K | $72.00K | $134.00K | $43.00K |
| Net income | -$10.67M | -$15.74M | -$17.14M | -$18.89M | -$19.17M | -$11.35M |
| EPS (diluted) | -$0.16 | -$0.24 | -$0.27 | -$0.30 | -$0.30 | -$0.18 |